[Gilles de la Tourette's disease based on five own observations].
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000175:diagnosis; D003192:Compulsive Behavior / Q000175:diagnosis; D003975:Diazepam / Q000627:therapeutic use; D003986:Dibenzocycloheptenes / Q000627:therapeutic use; D004454:Echolalia / Q000175:diagnosis; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008744:Methylamines; D010546:Perphenazine / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011612:Psychosurgery; D013064:Speech Disorders / Q000175:diagnosis; D013238:Stereotaxic Techniques; D013843:Thiazines / Q000627:therapeutic use; D013881:Thioridazine / Q000627:therapeutic use; D013981:Tic Disorders / Q000175:diagnosis; D005879:Tourette Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy
D003986:Dibenzocycloheptenes; D008744:Methylamines; D010640:Phenothiazines; D013843:Thiazines; D010546:Perphenazine; D006220:Haloperidol; D013881:Thioridazine; D003975:Diazepam
Zur Gilles de la Touretteschen Erkrankung anhand von fünfeigenen Beobachtungen.